The use of a compound of formula (I) or a salt, ester, amide or prodrug thereof; where X is O, or S, S(O) or S(O).sub.2, NH or NR.sup.12 where R.sup.12 is hydrogen or C.sub.1-6 alkyl; R.sup.5 is selected from a group NHC(O)OR.sup.9, NHC(O)R.sup.9, NHS(O).sub.2R.sup.9, C(O)R.sup.9, C(O)OR.sup.9, S(O)R.sup.9, S(O)OR.sup.9, S(O).sub.2OR.sup.9, C(O)NR.sup.10 R.sup.11, S(O)NR.sup.10R.sup.11 S(O)ONR.sup.10R.sup.11, where R.sup.9, R.sup.10 or R.sup.11 are various specified organic groups; R.sup.6 is hydrogen, optionally substituted hydrocarbyl or optionally substituted heterocyclyl; R.sup.7 and R.sup.8 are various specified organic groups, and R.sup.1, R.sup.2, R.sup.3, R.sup.4 are independently selected from halogeno, cyano, nitro, C.sub.1-3alkylsulphanyl, --N(OH)R.sup.13-- (wherein R.sup.7 is hydrogen, or C.sub.1-3alkyl), or R.sup.15X.sup.1-- (wherein X.sup.1 represents a direct bond, --O--, --CH.sub.2--, --OCO--, carbonyl, --S--, --SO--, --SO.sub.2--, --NR.sup.16CO--, --CONR.sup.16--, --SO.sub.2NR.sup.16--, --NR.sup.17SO.sub.2-- or --NR.sup.18-- (wherein R.sup.16, R.sup.17 and R.sup.18 each independently represents hydrogen, C.sub.1-3alkyl or C.sub.1-3alkoxy C.sub.2-3alkyl), and R.sup.9 is hydrogen, optionally substituted hydrocarbyl, optionally substituted heterocyclyl or optionally substituted alkoxy; in the preparation of a medicament for use in the inhibition of aurora 2 kinase. ##STR00001##
Claims The invention claimed is: 1. A compound of formula: ##STR00036## or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier. 3. A method of treating colorectal or breast cancer in a warm blooded animal in need of such treatment, which comprises administering to said animal an effective amount of a compound according to claim 1. 